Search
Close this search box.
×
Search
[custom_company_search_form]
Lithium
44.18
0.89%
Gold
2,638.60
0.7%
Copper
4.14
0.01%
Oil
67.20
(1.81%)
Bitcoin
99,758.34
(0.11%)
FTSE 100
8,308.60
(0.49%)
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,642.52
(0.41%)
Iron Ore
102.55
(1.19%)
USD/AUD
0.64
-0%
Hang Seng
19,865.85
1.3%
Lithium
44.18
0.89%
Gold
2,638.60
0.7%
Copper
4.14
0.01%
Oil
67.20
(1.81%)
Bitcoin
99,758.34
(0.11%)
FTSE 100
8,308.60
(0.49%)
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,642.52
(0.41%)
Iron Ore
102.55
(1.19%)
USD/AUD
0.64
-0%
Hang Seng
19,865.85
1.3%
Lithium
44.18
0.89%
Gold
2,638.60
0.7%
Copper
4.14
0.01%
Oil
67.20
(1.81%)
Bitcoin
99,758.34
(0.11%)
FTSE 100
8,308.60
(0.49%)
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,642.52
(0.41%)
Iron Ore
102.55
(1.19%)
USD/AUD
0.64
-0%
Hang Seng
19,865.85
1.3%
Lithium
44.18
0.89%
Gold
2,638.60
0.7%
Copper
4.14
0.01%
Oil
67.20
(1.81%)
Bitcoin
99,758.34
(0.11%)
FTSE 100
8,308.60
(0.49%)
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,642.52
(0.41%)
Iron Ore
102.55
(1.19%)
USD/AUD
0.64
-0%
Hang Seng
19,865.85
1.3%
Lithium
44.18
0.89%
Gold
2,638.60
0.7%
Copper
4.14
0.01%
Oil
67.20
(1.81%)
Bitcoin
99,758.34
(0.11%)
FTSE 100
8,308.60
(0.49%)
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,642.52
(0.41%)
Iron Ore
102.55
(1.19%)
USD/AUD
0.64
-0%
Hang Seng
19,865.85
1.3%
Lithium
44.18
0.89%
Gold
2,638.60
0.7%
Copper
4.14
0.01%
Oil
67.20
(1.81%)
Bitcoin
99,758.34
(0.11%)
FTSE 100
8,308.60
(0.49%)
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,642.52
(0.41%)
Iron Ore
102.55
(1.19%)
USD/AUD
0.64
-0%
Hang Seng
19,865.85
1.3%
Lithium
44.18
0.89%
Gold
2,638.60
0.7%
Copper
4.14
0.01%
Oil
67.20
(1.81%)
Bitcoin
99,758.34
(0.11%)
FTSE 100
8,308.60
(0.49%)
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,642.52
(0.41%)
Iron Ore
102.55
(1.19%)
USD/AUD
0.64
-0%
Hang Seng
19,865.85
1.3%
Lithium
44.18
0.89%
Gold
2,638.60
0.7%
Copper
4.14
0.01%
Oil
67.20
(1.81%)
Bitcoin
99,758.34
(0.11%)
FTSE 100
8,308.60
(0.49%)
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,642.52
(0.41%)
Iron Ore
102.55
(1.19%)
USD/AUD
0.64
-0%
Hang Seng
19,865.85
1.3%
Lithium
44.18
0.89%
Gold
2,638.60
0.7%
Copper
4.14
0.01%
Oil
67.20
(1.81%)
Bitcoin
99,758.34
(0.11%)
FTSE 100
8,308.60
(0.49%)
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,642.52
(0.41%)
Iron Ore
102.55
(1.19%)
USD/AUD
0.64
-0%
Hang Seng
19,865.85
1.3%
Lithium
44.18
0.89%
Gold
2,638.60
0.7%
Copper
4.14
0.01%
Oil
67.20
(1.81%)
Bitcoin
99,758.34
(0.11%)
FTSE 100
8,308.60
(0.49%)
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,642.52
(0.41%)
Iron Ore
102.55
(1.19%)
USD/AUD
0.64
-0%
Hang Seng
19,865.85
1.3%

Stock Piper AI Index

Stock Piper AI Index

Subscribe
Lithium
44.18
0.89%
Gold
2,638.60
0.7%
Copper
4.14
0.01%
Oil
67.20
(1.81%)
Bitcoin
99,758.34
(0.11%)
FTSE 100
8,308.60
(0.49%)
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,642.52
(0.41%)
Iron Ore
102.55
(1.19%)
USD/AUD
0.64
-0%
Hang Seng
19,865.85
1.3%
Lithium
44.18
0.89%
Gold
2,638.60
0.7%
Copper
4.14
0.01%
Oil
67.20
(1.81%)
Bitcoin
99,758.34
(0.11%)
FTSE 100
8,308.60
(0.49%)
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,642.52
(0.41%)
Iron Ore
102.55
(1.19%)
USD/AUD
0.64
-0%
Hang Seng
19,865.85
1.3%
Lithium
44.18
0.89%
Gold
2,638.60
0.7%
Copper
4.14
0.01%
Oil
67.20
(1.81%)
Bitcoin
99,758.34
(0.11%)
FTSE 100
8,308.60
(0.49%)
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,642.52
(0.41%)
Iron Ore
102.55
(1.19%)
USD/AUD
0.64
-0%
Hang Seng
19,865.85
1.3%
Lithium
44.18
0.89%
Gold
2,638.60
0.7%
Copper
4.14
0.01%
Oil
67.20
(1.81%)
Bitcoin
99,758.34
(0.11%)
FTSE 100
8,308.60
(0.49%)
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,642.52
(0.41%)
Iron Ore
102.55
(1.19%)
USD/AUD
0.64
-0%
Hang Seng
19,865.85
1.3%
Lithium
44.18
0.89%
Gold
2,638.60
0.7%
Copper
4.14
0.01%
Oil
67.20
(1.81%)
Bitcoin
99,758.34
(0.11%)
FTSE 100
8,308.60
(0.49%)
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,642.52
(0.41%)
Iron Ore
102.55
(1.19%)
USD/AUD
0.64
-0%
Hang Seng
19,865.85
1.3%
Lithium
44.18
0.89%
Gold
2,638.60
0.7%
Copper
4.14
0.01%
Oil
67.20
(1.81%)
Bitcoin
99,758.34
(0.11%)
FTSE 100
8,308.60
(0.49%)
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,642.52
(0.41%)
Iron Ore
102.55
(1.19%)
USD/AUD
0.64
-0%
Hang Seng
19,865.85
1.3%
Lithium
44.18
0.89%
Gold
2,638.60
0.7%
Copper
4.14
0.01%
Oil
67.20
(1.81%)
Bitcoin
99,758.34
(0.11%)
FTSE 100
8,308.60
(0.49%)
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,642.52
(0.41%)
Iron Ore
102.55
(1.19%)
USD/AUD
0.64
-0%
Hang Seng
19,865.85
1.3%
Lithium
44.18
0.89%
Gold
2,638.60
0.7%
Copper
4.14
0.01%
Oil
67.20
(1.81%)
Bitcoin
99,758.34
(0.11%)
FTSE 100
8,308.60
(0.49%)
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,642.52
(0.41%)
Iron Ore
102.55
(1.19%)
USD/AUD
0.64
-0%
Hang Seng
19,865.85
1.3%
Lithium
44.18
0.89%
Gold
2,638.60
0.7%
Copper
4.14
0.01%
Oil
67.20
(1.81%)
Bitcoin
99,758.34
(0.11%)
FTSE 100
8,308.60
(0.49%)
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,642.52
(0.41%)
Iron Ore
102.55
(1.19%)
USD/AUD
0.64
-0%
Hang Seng
19,865.85
1.3%
Lithium
44.18
0.89%
Gold
2,638.60
0.7%
Copper
4.14
0.01%
Oil
67.20
(1.81%)
Bitcoin
99,758.34
(0.11%)
FTSE 100
8,308.60
(0.49%)
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,642.52
(0.41%)
Iron Ore
102.55
(1.19%)
USD/AUD
0.64
-0%
Hang Seng
19,865.85
1.3%

Opyl Ltd

OPL

ASX

Opyl (OPL, formerly ShareRoot Ltd) is a frontrunner among Australian digital health companies, leveraging the power of artificial intelligence to revolutionize clinical trials. By integrating AI throughout the process, Opyl goes beyond simply conducting trials - they aim to improve their efficiency and predict outcomes, ultimately leading to faster development of new treatments.

Latest Posts

Line Chart with Gradient
Price
$0.029
-0.001 (-3.33%)
At Close 06/12 (AEST)
Related Companies
OBJECTIVE CORPORATION LIMITED
$OCL
FIRSTWAVE CLOUD TECHNOLOGY LIMITED
$FCT
RECKON LIMITED
$RKN
PHARMX TECHNOLOGIES LIMITED
$PHX
INFOMEDIA LTD
$IFM

Leave a Comment on OPL


Comments for OPL

    Latest Posts

    opyl-asx-opl-enters-agreement-with-southern-cdc-opl
    Information Technology $OPL
    Opyl (ASX: $OPL) enters agreement with Southern CDCNew partnership enhances clinical trial optimization with AI-powered TrialKey platform
    November 21, 2024
    opyl-asx-opl-signs-new-service-agreement-with-biointelect-opl
    Information Technology $OPL

    Opyl (ASX: $OPL) signs new service agreement with Biointelect

    Collaboration to optimize clinical trial outcomes and strategies through TrialKey platform

    September 25, 2024
    opyl-asx-opl-enters-strategic-partnership-with-phenix-healths-compendium-platform-opl
    Information Technology $OPL

    Opyl (ASX: $OPL) enters strategic partnership with phenix health's compendium platform

    Collaboration to validate clinical trials associated with cannabis products using Al-powered TrialKey platform

    September 23, 2024
    opyl-asx-opl-enters-strategic-partnership-with-alithia-life-sciences-opl
    Information Technology $OPL

    Opyl (ASX: $OPL) enters strategic partnership with Alithia Life Sciences

    Collaboration to enhance clinical trial projects with Al-driven analytics

    September 17, 2024
    opyl-asx-opl-completes-successful-rights-issue-shortfall-placement-opl
    Information Technology $OPL

    Opyl (ASX: $OPL) completes successful rights issue shortfall placement

    Raises $1,433,358 for critical initiatives including TrialKey commercialisation strategy

    August 21, 2024
    opyl-asx-opl-announces-first-trial-gen-revenue-and-inaugural-customer-brain-vector-opl
    Information Technology $OPL

    Opyl (ASX: $OPL) announces first trial gen revenue and inaugural customer: Brain Vector

    TrialKey secures first contract with Brain Vector for mental healthcare services

    June 6, 2024
    opyl-asx-opl-signs-binding-agreement-for-divestment-of-opin-opl
    Information Technology $OPL

    Opyl (ASX: $OPL) signs binding agreement for divestment of opin

    Dr Stephenson to invest $1.2 million in Opin, Opyl retains 20% share

    April 24, 2024
    opyl-asx-opl-requests-voluntary-suspension-for-non-binding-offer-opl
    Information Technology $OPL

    Opyl (ASX: $OPL) requests voluntary suspension for non-binding offer

    Request for suspension pending announcement of non-binding offer for Opin business

    March 22, 2024
    opyl-asx-opl-requests-trading-halt-pending-announcement-opl
    Information Technology $OPL

    Opyl (ASX: $OPL) requests trading halt pending announcement

    ASX-listed Opyl Limited requests trading halt ahead of upcoming announcement

    March 20, 2024
    opyl-asx-opl-pauses-trading-pending-further-announcement-opl
    Information Technology $OPL

    Opyl (ASX: $OPL) pauses trading pending further announcement

    Trading temporarily paused awaiting additional news from Opyl Limited

    March 20, 2024
    opyl-asx-opl-requests-voluntary-suspension-for-equity-raising-opl
    Information Technology $OPL

    Opyl (ASX: $OPL) requests voluntary suspension for equity raising

    Company requests suspension for capital raise and Entitlement Offer

    January 14, 2024
    opyl-asx-opl-completes-placement-and-launches-entitlement-offer-opl
    Information Technology $OPL

    Opyl (ASX: $OPL) completes placement and launches entitlement offer

    Raises $576,000 from successful placement and offers non-renounceable rights issue at $0.03 per share

    January 12, 2024
    opyl-asxopl-requests-trading-halt-for-proposed-capital-raising-opl
    Information Technology $OPL

    Opyl (ASX:OPL) requests trading halt for proposed capital raising

    Company requests halt for capital raising announcement

    December 19, 2023
    opyl-asxopl-requests-voluntary-suspension-for-equity-raising-opl
    Information Technology $OPL

    Opyl (ASX:$OPL) requests voluntary suspension for equity raising

    Company requests suspension for capital raise and Entitlement Offer

    December 13, 2023
    opyl-asxopl-completes-placement-and-launches-entitlement-offer-opl
    Information Technology $OPL

    Opyl (ASX:$OPL) completes placement and launches entitlement offer

    Raises $576,000 from successful placement and offers non-renounceable rights issue at $0.03 per share

    December 13, 2023

    OPL

    $OPL

    Opyl (ASX: $OPL) enters agreement with Southern CDC

    New partnership enhances clinical trial optimization with AI-powered TrialKey platform

    OPL

    $OPL

    Opyl (ASX: $OPL) signs new service agreement with Biointelect

    Collaboration to optimize clinical trial outcomes and strategies through TrialKey platform

    OPL

    $OPL

    Opyl (ASX: $OPL) enters strategic partnership with phenix health's compendium platform

    Collaboration to validate clinical trials associated with cannabis products using Al-powered TrialKey platform

    OPL

    $OPL

    Opyl (ASX: $OPL) enters strategic partnership with Alithia Life Sciences

    Collaboration to enhance clinical trial projects with Al-driven analytics

    OPL

    $OPL

    Opyl (ASX: $OPL) completes successful rights issue shortfall placement

    Raises $1,433,358 for critical initiatives including TrialKey commercialisation strategy

    OPL

    $OPL

    Opyl (ASX: $OPL) announces first trial gen revenue and inaugural customer: Brain Vector

    TrialKey secures first contract with Brain Vector for mental healthcare services

    OPL

    $OPL

    Opyl (ASX: $OPL) signs binding agreement for divestment of opin

    Dr Stephenson to invest $1.2 million in Opin, Opyl retains 20% share

    OPL

    $OPL

    Opyl (ASX: $OPL) requests voluntary suspension for non-binding offer

    Request for suspension pending announcement of non-binding offer for Opin business

    OPL

    $OPL

    Opyl (ASX: $OPL) requests trading halt pending announcement

    ASX-listed Opyl Limited requests trading halt ahead of upcoming announcement

    OPL

    $OPL

    Opyl (ASX: $OPL) pauses trading pending further announcement

    Trading temporarily paused awaiting additional news from Opyl Limited

    Load More
    No More Posts
    Related Companies
    COSOL LIMITED
    $COS
    COMPLII FINTECH SOLUTIONS LTD
    $CF1
    K2FLY LIMITED
    $K2F
    5G NETWORKS LIMITED.
    $5GN
    ICETANA LIMITED
    $ICE

    ASX News, First
    & Fast.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    By clicking Subscribe, you agree to our Terms & Conditions
    © 2024 Stock Piper.
    All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support

    Socials

    Facebook
    Twitter
    LinkedIn
    © 2024 Stock Piper. All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support
    © 2024 Stock Piper. All rights reserved
    Social Media Auto Publish Powered By : XYZScripts.com
    Stock Piper AI Index
    Subscribe
    Join FREE Newsletter

    Stock Piper AI Index Coming Soon!

    Join our Newsletter to gain exclusive insight and be notified once we are live.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    Get all the latest market updates straight to your inbox.

    By clicking Subscribe, you agree to our Terms & Conditions